准代谢途径可以增强对固体瘤的CAR-T功效
Wenying Li1, Jiannan Chen1, Zhigang Guo1
1Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China.
International immunopharmacology
|October 25, 2024
概括
向瘤代谢可以增强化学抗原受体 (CAR) T细胞治疗固体瘤. 解决代谢竞争和免疫抑制可以改善CAR T细胞功能和存活率,促进抗癌免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢工程是代谢工程.
- 在瘤学瘤学.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法对血液癌症具有前景,但在固体瘤中面临挑战.
- 卡尔T细胞的疗效受到过早疲的限制,通常是由于代谢能量不足和瘤的敌对微环境造成的.
- 瘤细胞重编程新陈代谢,导致竞争和免疫抑制,损害CAR T细胞功能.
研究的目的:
- 探索瘤微环境中的向代谢途径如何增强CAR T细胞治疗.
- 解决影响CAR T细胞功能和生存的代谢竞争和免疫抑制问题.
- 审查免疫代谢机制的进展,并确定改善CAR T细胞治疗的潜在代谢标.
主要方法:
- 在瘤-免疫细胞相互作用的背景下,对葡萄糖,脂质和氨基酸代谢的最新研究进行审查.
- 分析瘤代谢重编程如何影响免疫细胞代谢并促进免疫抑制.
- 识别可以增强抗瘤免疫反应的代谢干预措施.
主要成果:
- 瘤和T细胞的不同代谢需求创造了一个不利于CAR T细胞治疗的竞争环境.
- 准代谢途径 (葡萄糖,脂质,氨基酸) 可以增强抗瘤免疫反应.
- 代谢干预可以满足CAR T细胞的能量需求,克服疲.
结论:
- 向瘤免疫代谢提供了一种有前途的策略,以改善CAR T细胞治疗在固体瘤中的疗效.
- 将代谢干预与现有疗法相结合可以增强CAR T细胞功能和存活率.
- 对瘤免疫代谢机制的进一步研究可以导致新的治疗策略.
相关概念视频
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


